Global Sorafenib Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Sorafenib Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Sorafenib by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Sorafenib by Country/Region, 2017, 2022 & 2028

2.2 Sorafenib Segment by Type

2.2.1 Patented Drugs

2.2.2 Generic Drugs

2.3 Sorafenib Sales by Type

2.3.1 Global Sorafenib Sales Market Share by Type (2017-2022)

2.3.2 Global Sorafenib Revenue and Market Share by Type (2017-2022)

2.3.3 Global Sorafenib Sale Price by Type (2017-2022)

2.4 Sorafenib Segment by Application

2.4.1 Kidney Cancer

2.4.2 Liver Cancer

2.4.3 Thyroid Cancer

2.4.4 Other

2.5 Sorafenib Sales by Application

2.5.1 Global Sorafenib Sale Market Share by Application (2017-2022)

2.5.2 Global Sorafenib Revenue and Market Share by Application (2017-2022)

2.5.3 Global Sorafenib Sale Price by Application (2017-2022)

3 Global Sorafenib by Company

3.1 Global Sorafenib Breakdown Data by Company

3.1.1 Global Sorafenib Annual Sales by Company (2020-2022)

3.1.2 Global Sorafenib Sales Market Share by Company (2020-2022)

3.2 Global Sorafenib Annual Revenue by Company (2020-2022)

3.2.1 Global Sorafenib Revenue by Company (2020-2022)

3.2.2 Global Sorafenib Revenue Market Share by Company (2020-2022)

3.3 Global Sorafenib Sale Price by Company

3.4 Key Manufacturers Sorafenib Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Sorafenib Product Location Distribution

3.4.2 Players Sorafenib Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Sorafenib by Geographic Region

4.1 World Historic Sorafenib Market Size by Geographic Region (2017-2022)

4.1.1 Global Sorafenib Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Sorafenib Annual Revenue by Geographic Region

4.2 World Historic Sorafenib Market Size by Country/Region (2017-2022)

4.2.1 Global Sorafenib Annual Sales by Country/Region (2017-2022)

4.2.2 Global Sorafenib Annual Revenue by Country/Region

4.3 Americas Sorafenib Sales Growth

4.4 APAC Sorafenib Sales Growth

4.5 Europe Sorafenib Sales Growth

4.6 Middle East & Africa Sorafenib Sales Growth

5 Americas

5.1 Americas Sorafenib Sales by Country

5.1.1 Americas Sorafenib Sales by Country (2017-2022)

5.1.2 Americas Sorafenib Revenue by Country (2017-2022)

5.2 Americas Sorafenib Sales by Type

5.3 Americas Sorafenib Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Sorafenib Sales by Region

6.1.1 APAC Sorafenib Sales by Region (2017-2022)

6.1.2 APAC Sorafenib Revenue by Region (2017-2022)

6.2 APAC Sorafenib Sales by Type

6.3 APAC Sorafenib Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Sorafenib by Country

7.1.1 Europe Sorafenib Sales by Country (2017-2022)

7.1.2 Europe Sorafenib Revenue by Country (2017-2022)

7.2 Europe Sorafenib Sales by Type

7.3 Europe Sorafenib Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Sorafenib by Country

8.1.1 Middle East & Africa Sorafenib Sales by Country (2017-2022)

8.1.2 Middle East & Africa Sorafenib Revenue by Country (2017-2022)

8.2 Middle East & Africa Sorafenib Sales by Type

8.3 Middle East & Africa Sorafenib Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Sorafenib

10.3 Manufacturing Process Analysis of Sorafenib

10.4 Industry Chain Structure of Sorafenib

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Sorafenib Distributors

11.3 Sorafenib Customer

12 World Forecast Review for Sorafenib by Geographic Region

12.1 Global Sorafenib Market Size Forecast by Region

12.1.1 Global Sorafenib Forecast by Region (2023-2028)

12.1.2 Global Sorafenib Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Sorafenib Forecast by Type

12.7 Global Sorafenib Forecast by Application

13 Key Players Analysis

13.1 Bayer

13.1.1 Bayer Company Information

13.1.2 Bayer Sorafenib Product Offered

13.1.3 Bayer Sorafenib Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bayer Main Business Overview

13.1.5 Bayer Latest Developments

13.2 Natco Pharma

13.2.1 Natco Pharma Company Information

13.2.2 Natco Pharma Sorafenib Product Offered

13.2.3 Natco Pharma Sorafenib Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Natco Pharma Main Business Overview

13.2.5 Natco Pharma Latest Developments

13.3 Cipla

13.3.1 Cipla Company Information

13.3.2 Cipla Sorafenib Product Offered

13.3.3 Cipla Sorafenib Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Cipla Main Business Overview

13.3.5 Cipla Latest Developments

13.4 Mylan

13.4.1 Mylan Company Information

13.4.2 Mylan Sorafenib Product Offered

13.4.3 Mylan Sorafenib Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Mylan Main Business Overview

13.4.5 Mylan Latest Developments

14 Research Findings and Conclusion

Table 1. Sorafenib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Sorafenib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Patented Drugs

Table 4. Major Players of Generic Drugs

Table 5. Global Sorafenib Sales by Type (2017-2022) & (K Units)

Table 6. Global Sorafenib Sales Market Share by Type (2017-2022)

Table 7. Global Sorafenib Revenue by Type (2017-2022) & ($ million)

Table 8. Global Sorafenib Revenue Market Share by Type (2017-2022)

Table 9. Global Sorafenib Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Sorafenib Sales by Application (2017-2022) & (K Units)

Table 11. Global Sorafenib Sales Market Share by Application (2017-2022)

Table 12. Global Sorafenib Revenue by Application (2017-2022)

Table 13. Global Sorafenib Revenue Market Share by Application (2017-2022)

Table 14. Global Sorafenib Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Sorafenib Sales by Company (2020-2022) & (K Units)

Table 16. Global Sorafenib Sales Market Share by Company (2020-2022)

Table 17. Global Sorafenib Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Sorafenib Revenue Market Share by Company (2020-2022)

Table 19. Global Sorafenib Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Sorafenib Producing Area Distribution and Sales Area

Table 21. Players Sorafenib Products Offered

Table 22. Sorafenib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Sorafenib Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Sorafenib Sales Market Share Geographic Region (2017-2022)

Table 27. Global Sorafenib Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Sorafenib Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Sorafenib Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Sorafenib Sales Market Share by Country/Region (2017-2022)

Table 31. Global Sorafenib Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Sorafenib Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Sorafenib Sales by Country (2017-2022) & (K Units)

Table 34. Americas Sorafenib Sales Market Share by Country (2017-2022)

Table 35. Americas Sorafenib Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Sorafenib Revenue Market Share by Country (2017-2022)

Table 37. Americas Sorafenib Sales by Type (2017-2022) & (K Units)

Table 38. Americas Sorafenib Sales Market Share by Type (2017-2022)

Table 39. Americas Sorafenib Sales by Application (2017-2022) & (K Units)

Table 40. Americas Sorafenib Sales Market Share by Application (2017-2022)

Table 41. APAC Sorafenib Sales by Region (2017-2022) & (K Units)

Table 42. APAC Sorafenib Sales Market Share by Region (2017-2022)

Table 43. APAC Sorafenib Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Sorafenib Revenue Market Share by Region (2017-2022)

Table 45. APAC Sorafenib Sales by Type (2017-2022) & (K Units)

Table 46. APAC Sorafenib Sales Market Share by Type (2017-2022)

Table 47. APAC Sorafenib Sales by Application (2017-2022) & (K Units)

Table 48. APAC Sorafenib Sales Market Share by Application (2017-2022)

Table 49. Europe Sorafenib Sales by Country (2017-2022) & (K Units)

Table 50. Europe Sorafenib Sales Market Share by Country (2017-2022)

Table 51. Europe Sorafenib Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Sorafenib Revenue Market Share by Country (2017-2022)

Table 53. Europe Sorafenib Sales by Type (2017-2022) & (K Units)

Table 54. Europe Sorafenib Sales Market Share by Type (2017-2022)

Table 55. Europe Sorafenib Sales by Application (2017-2022) & (K Units)

Table 56. Europe Sorafenib Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Sorafenib Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Sorafenib Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Sorafenib Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Sorafenib Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Sorafenib Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Sorafenib Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Sorafenib Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Sorafenib Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Sorafenib

Table 66. Key Market Challenges & Risks of Sorafenib

Table 67. Key Industry Trends of Sorafenib

Table 68. Sorafenib Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Sorafenib Distributors List

Table 71. Sorafenib Customer List

Table 72. Global Sorafenib Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Sorafenib Sales Market Forecast by Region

Table 74. Global Sorafenib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Sorafenib Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Sorafenib Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Sorafenib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Sorafenib Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Sorafenib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Sorafenib Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Sorafenib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Sorafenib Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Sorafenib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Sorafenib Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Sorafenib Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Sorafenib Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Sorafenib Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Sorafenib Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Sorafenib Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Sorafenib Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Sorafenib Revenue Market Share Forecast by Application (2023-2028)

Table 92. Bayer Basic Information, Sorafenib Manufacturing Base, Sales Area and Its Competitors

Table 93. Bayer Sorafenib Product Offered

Table 94. Bayer Sorafenib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Bayer Main Business

Table 96. Bayer Latest Developments

Table 97. Natco Pharma Basic Information, Sorafenib Manufacturing Base, Sales Area and Its Competitors

Table 98. Natco Pharma Sorafenib Product Offered

Table 99. Natco Pharma Sorafenib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Natco Pharma Main Business

Table 101. Natco Pharma Latest Developments

Table 102. Cipla Basic Information, Sorafenib Manufacturing Base, Sales Area and Its Competitors

Table 103. Cipla Sorafenib Product Offered

Table 104. Cipla Sorafenib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Cipla Main Business

Table 106. Cipla Latest Developments

Table 107. Mylan Basic Information, Sorafenib Manufacturing Base, Sales Area and Its Competitors

Table 108. Mylan Sorafenib Product Offered

Table 109. Mylan Sorafenib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Mylan Main Business

Table 111. Mylan Latest Developments

List of Figures

Figure 1. Picture of Sorafenib

Figure 2. Sorafenib Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Sorafenib Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Sorafenib Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Sorafenib Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Patented Drugs

Figure 10. Product Picture of Generic Drugs

Figure 11. Global Sorafenib Sales Market Share by Type in 2021

Figure 12. Global Sorafenib Revenue Market Share by Type (2017-2022)

Figure 13. Sorafenib Consumed in Kidney Cancer

Figure 14. Global Sorafenib Market: Kidney Cancer (2017-2022) & (K Units)

Figure 15. Sorafenib Consumed in Liver Cancer

Figure 16. Global Sorafenib Market: Liver Cancer (2017-2022) & (K Units)

Figure 17. Sorafenib Consumed in Thyroid Cancer

Figure 18. Global Sorafenib Market: Thyroid Cancer (2017-2022) & (K Units)

Figure 19. Sorafenib Consumed in Other

Figure 20. Global Sorafenib Market: Other (2017-2022) & (K Units)

Figure 21. Global Sorafenib Sales Market Share by Application (2017-2022)

Figure 22. Global Sorafenib Revenue Market Share by Application in 2021

Figure 23. Sorafenib Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Sorafenib Revenue Market Share by Company in 2021

Figure 25. Global Sorafenib Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Sorafenib Revenue Market Share by Geographic Region in 2021

Figure 27. Global Sorafenib Sales Market Share by Region (2017-2022)

Figure 28. Global Sorafenib Revenue Market Share by Country/Region in 2021

Figure 29. Americas Sorafenib Sales 2017-2022 (K Units)

Figure 30. Americas Sorafenib Revenue 2017-2022 ($ Millions)

Figure 31. APAC Sorafenib Sales 2017-2022 (K Units)

Figure 32. APAC Sorafenib Revenue 2017-2022 ($ Millions)

Figure 33. Europe Sorafenib Sales 2017-2022 (K Units)

Figure 34. Europe Sorafenib Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Sorafenib Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Sorafenib Revenue 2017-2022 ($ Millions)

Figure 37. Americas Sorafenib Sales Market Share by Country in 2021

Figure 38. Americas Sorafenib Revenue Market Share by Country in 2021

Figure 39. United States Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Sorafenib Sales Market Share by Region in 2021

Figure 44. APAC Sorafenib Revenue Market Share by Regions in 2021

Figure 45. China Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Sorafenib Sales Market Share by Country in 2021

Figure 52. Europe Sorafenib Revenue Market Share by Country in 2021

Figure 53. Germany Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Sorafenib Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Sorafenib Revenue Market Share by Country in 2021

Figure 60. Egypt Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Sorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Sorafenib in 2021

Figure 66. Manufacturing Process Analysis of Sorafenib

Figure 67. Industry Chain Structure of Sorafenib

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles